SCHEMBL20550992

SCHEMBL20550992

C[Si](C)(c1cccs1)[Si](C)(C)c1cccs1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.36
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 5/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
HPGD P15428 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
RAB9A P51151 5/20 0.34
NPC1 O15118 4/20 0.34
SMN1; SMN2 Q16637 5/20 0.33
NFKB1 P19838 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2341397 0.83
SCHEMBL2290788 0.83 FBP1 (0.36) FBP1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL2177738 0.79
SCHEMBL9190818 0.79 ALDH1A1 (0.33) FBP1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL8983864 0.79
SCHEMBL4351074 0.77 TDO2 (0.33) FBP1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL8912674 0.77 FBP1 (0.39) FBP1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL7739043 0.74 NR1H2 (0.37) KDM4EALDH1A1HPGDTAAR1MEN1
SCHEMBL14759822 0.74 CES2 (0.41) KDM4EALDH1A1L3MBTL1MEN1MAPT
SCHEMBL29249788 0.74 KDM4E (0.36) FBP1KDM4EALDH1A1L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200275656-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2020-09-03 US disclosed
EP-3619197-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES Bayer Aktiengesellschaft (DE) 2020-03-11 EP disclosed
WO-2018202712-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2018-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200275656-A1 TRISUBSTITUTEDSILYLMETHYLPHENOXYQUINOLINES AND ANALOGUES PIK3C3, DDT, ERG28 FBP1 1138/4885KDM4E 203/4885ALDH1A1 3077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.